BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8380270)

  • 1. Oxytocin induced cAMP-dependent protein kinase activation and urokinase-type plasminogen activator production in LLC-PK1 renal epithelial cells is mediated by the vasopressin V2-receptor.
    Jans DA; Pavo I; Fahrenholz F
    FEBS Lett; 1993 Jan; 315(2):134-8. PubMed ID: 8380270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.
    Leitman DC; Agnost VL; Catalano RM; Schröder H; Waldman SA; Bennett BM; Tuan JJ; Murad F
    Endocrinology; 1988 Apr; 122(4):1478-85. PubMed ID: 2894298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells.
    Jans DA; Resink TJ; Hemmings BA
    Biochem J; 1987 Apr; 243(2):413-8. PubMed ID: 2820380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel LLC-PK1 renal epithelial cell mutant impaired in in vivo down-regulation of cAMP-mediated hormonal response.
    Jans DA; Resink TJ; Hemmings BA
    Arch Biochem Biophys; 1991 Mar; 285(2):377-81. PubMed ID: 1716864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP-dependent protein kinase activation affects vasopressin V2-receptor number and internalization in LLC-PK1 renal epithelial cells.
    Jans DA; Hemmings BA
    FEBS Lett; 1991 Apr; 281(1-2):267-71. PubMed ID: 1707831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pharmacology of human vasopressin receptors.
    Thibonnier M; Conarty DM; Preston JA; Wilkins PL; Berti-Mattera LN; Mattera R
    Adv Exp Med Biol; 1998; 449():251-76. PubMed ID: 10026814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of phosphoinositide hydrolysis by oxytocin in renal epithelial cells.
    Garg LC; Wozniak M; Phillips MI
    J Pharmacol Exp Ther; 1990 Feb; 252(2):552-7. PubMed ID: 2156051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and genetic characterization of a renal epithelial cell mutant defective in vasopressin (V2) receptor binding and function.
    Luzius H; Jans DA; Jans P; Fahrenholz F
    Exp Cell Res; 1991 Aug; 195(2):478-84. PubMed ID: 1649058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin receptors from LLC-PK1 cells: expression in Xenopus oocytes.
    Cantau B; Barjon JN; Chicot D; Baskevitch PP; Jard S
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F963-72. PubMed ID: 2158746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotinyl analogues of vasopressin as biologically active probes for vasopressin receptor expression in cultured cells.
    Jans DA; Bergmann L; Peters R; Fahrenholz F
    J Biol Chem; 1990 Aug; 265(24):14599-605. PubMed ID: 2143764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LLC-PK1 cell mutants in cAMP metabolism respond normally to phorbol esters.
    Jans DA; Hemmings BA
    FEBS Lett; 1986 Sep; 205(1):127-31. PubMed ID: 3017754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
    Stassen FL; Heckman G; Schmidt D; Papadopoulos MT; Nambi P; Sarau H; Aiyar N; Gellai M; Kinter L
    Mol Pharmacol; 1988 Feb; 33(2):218-24. PubMed ID: 2828915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
    Ziegler A; Knesel J; Fabbro D; Nagamine Y
    J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A system to select for mutant LLC-PK1 cells affected in cAMP mediated hormonal response using a photoactivatable analogue of vasopressin.
    Luzius H; Jans DA; Fahrenholz F
    J Recept Res; 1990; 10(1-2):61-80. PubMed ID: 2175811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway of urokinase-type plasminogen activator induction in the T47D and LLC-PK1 cell lines.
    Jans DA; Dierks-Ventling C; Hemmings BA
    Exp Cell Res; 1987 Sep; 172(1):76-83. PubMed ID: 3653259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK1 renal epithelial cells: role of the cytoskeleton.
    Jans DA; Peters R; Jans P; Fahrenholz F
    Exp Cell Res; 1990 Nov; 191(1):121-8. PubMed ID: 2146138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells.
    Ozaki S; Ihara M; Saeki T; Fukami T; Ishikawa K; Yano M
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1035-40. PubMed ID: 7932150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine vasopressin and oxytocin increase intracellular calcium and cAMP in human glomerular epithelial cells in culture.
    Späth M; Pavenstädt H; Petersen J; Schollmeyer P
    Kidney Blood Press Res; 1996; 19(2):81-6. PubMed ID: 8871886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.